HIV-1 and coinfection with hepatitis B and delta viruses: What is the impact of HIV-1 infection on hepatitis B chronic carriage and the sero-prevalence of delta virus in Uganda?
Main Author: | |
---|---|
Language: | English |
Published: |
Case Western Reserve University School of Graduate Studies / OhioLINK
1994
|
Subjects: | |
Online Access: | http://rave.ohiolink.edu/etdc/view?acc_num=case1057847652 |
id |
ndltd-OhioLink-oai-etd.ohiolink.edu-case1057847652 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-OhioLink-oai-etd.ohiolink.edu-case10578476522021-08-03T05:31:04Z HIV-1 and coinfection with hepatitis B and delta viruses: What is the impact of HIV-1 infection on hepatitis B chronic carriage and the sero-prevalence of delta virus in Uganda? Opio, Alex Achol HIV-1 coinfection hepatitis B delta viruses impact HIV-1 infection hepatitis B chronic carriage sero-prevalence delta virus Uganda? Since clearance of HBV infection is dependent on normally functioning cell-mediated immunity, it is possible that immunological dysfunction induced by HIV-1 infection leads to poor clearance of HBV. Consequently, HIV infection is expected to promote the spread of HBV infection. To determine whether HIV infection has the potential to promote the spread of HBV infection, a hospital-based cross-sectional study was conducted in Uganda. Information was collected on respondent's demographic characteristics, risk factors for, and clinical features of HBV infection. In addition, blood was obtained for HIV-1 and hepatitis tests. The overall prevalence of HBsAg, anti-HBs, anti-HBc and total HBV infection was 15.7%, 54.0%, 42.9% and 66.9% respectively. 64.4% of subjects with detectable levels of anti-HBs had "protective levels" of the antibody. Of 1392 subjects tested for all the three key markers of HBV infection (HBsAg, anti-HBs and anti-HBc), 463 (33.2%) had no evidence of infection, 51 (3.7%) were in a serologic window period, 210 (15.1%) had evidence of infection that occurred in the distant past, 450 (32.3%) were i n convalescence, and 218 (15.5%) had active infection. Of 218 subjects with active infection, 111 (50.9%) were in the early phases of infection, 96 (44.1%) had either acute or chronic hepatitis, and 11 (5.0%) had reinfections. 43 subjects had concurrent circulation of HBsAg and anti-HBs. The overall prevalence of HBV chronic carriage was 4.9%. HIV positive individuals were more likely than those negative to have chronic carriage (P = 0.0007). After controlling for other variables, being HIV positive was associated with a 3.66 fold increase in the likelihood of chronic carriage. Being a male or having both fever and fatigue were independently predictive of HBV chronic carriage. Of 172 HBsAg positive subjects tested for anti-HD, 4 (2.3%) had the antibody. Of 152 HBsAg positive subjects tested for HBeAg, 23 (15.1%) had the antigen. There was no difference in HBeAg seropositivity by HIV status (P > 0.05). In conclusion, the study shows that HBV infection is highly endemic in Uganda, HDV infection is not a problem in southern Uganda, HIV infection has the potential to promote HBV chronic carriage, and, presence of anti-HBs may not always represent immunity. Ensuing from above, recommendations are made: (a) Institution of HB vaccination programme, (b) Prevention of HBV infection through blood screening and sterilization of injection/surgical equipments, (c) Continued prevention of HIV infection through counselling, (d) Further research to find out how maternal transmission of HBV is impacted by HIV infection, and to elucidate the subject of co-occurrence of HBsAg and anti-HBs. 1994 English text Case Western Reserve University School of Graduate Studies / OhioLINK http://rave.ohiolink.edu/etdc/view?acc_num=case1057847652 http://rave.ohiolink.edu/etdc/view?acc_num=case1057847652 unrestricted This thesis or dissertation is protected by copyright: all rights reserved. It may not be copied or redistributed beyond the terms of applicable copyright laws. |
collection |
NDLTD |
language |
English |
sources |
NDLTD |
topic |
HIV-1 coinfection hepatitis B delta viruses impact HIV-1 infection hepatitis B chronic carriage sero-prevalence delta virus Uganda? |
spellingShingle |
HIV-1 coinfection hepatitis B delta viruses impact HIV-1 infection hepatitis B chronic carriage sero-prevalence delta virus Uganda? Opio, Alex Achol HIV-1 and coinfection with hepatitis B and delta viruses: What is the impact of HIV-1 infection on hepatitis B chronic carriage and the sero-prevalence of delta virus in Uganda? |
author |
Opio, Alex Achol |
author_facet |
Opio, Alex Achol |
author_sort |
Opio, Alex Achol |
title |
HIV-1 and coinfection with hepatitis B and delta viruses: What is the impact of HIV-1 infection on hepatitis B chronic carriage and the sero-prevalence of delta virus in Uganda? |
title_short |
HIV-1 and coinfection with hepatitis B and delta viruses: What is the impact of HIV-1 infection on hepatitis B chronic carriage and the sero-prevalence of delta virus in Uganda? |
title_full |
HIV-1 and coinfection with hepatitis B and delta viruses: What is the impact of HIV-1 infection on hepatitis B chronic carriage and the sero-prevalence of delta virus in Uganda? |
title_fullStr |
HIV-1 and coinfection with hepatitis B and delta viruses: What is the impact of HIV-1 infection on hepatitis B chronic carriage and the sero-prevalence of delta virus in Uganda? |
title_full_unstemmed |
HIV-1 and coinfection with hepatitis B and delta viruses: What is the impact of HIV-1 infection on hepatitis B chronic carriage and the sero-prevalence of delta virus in Uganda? |
title_sort |
hiv-1 and coinfection with hepatitis b and delta viruses: what is the impact of hiv-1 infection on hepatitis b chronic carriage and the sero-prevalence of delta virus in uganda? |
publisher |
Case Western Reserve University School of Graduate Studies / OhioLINK |
publishDate |
1994 |
url |
http://rave.ohiolink.edu/etdc/view?acc_num=case1057847652 |
work_keys_str_mv |
AT opioalexachol hiv1andcoinfectionwithhepatitisbanddeltaviruseswhatistheimpactofhiv1infectiononhepatitisbchroniccarriageandtheseroprevalenceofdeltavirusinuganda |
_version_ |
1719421194336206848 |